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Introduction. Advances techniques are indicated for the treatment of acoustic neuromas. We use Linear Accelerator (Linac) Precise
with Dynamics Arcs Radiotherapy (DART) with Micromultiláminas and recently an optimizacion of treatments is added with the
Image Guided Radiotherapy (IGRT) and Hexapod table.
Objectives. Report the value of stereotactic radiosurgery (SRS) and fractionated stereotactic radiotherapy (RTEF) on local control
of acoustic neuromas.
Method. From April 2005 to January 2013, 59 patients were treated with acoustic neuromas. 57 cases were unilateral and two
cases were patients with neuroﬁbromatosis type II. 50 patients received SRS with doses of 12 Gy (excluding 2 patients with 13 Gy
and 14 Gy) and 9 patients have received RTEF due to tumor size, performance status or refuse the ﬁxed frame. The prescription
doses were 54 Gy 1.8 Gy per fraction, 50 Gy 2 Gy per fraction and other with altered fractionation. The tumor volume ranged
from 0.2 and 29.6 cc. (median 2.9 cc). Hearing loss, tinnitus and dizziness are the inicial symthoms. Treatment is indicated in
asymptomatic patients when tumor size is over 1 cm.
Results. Median follow-up is 23 months (1-94). The same tumor size remain in 24 neurinomas (40%), in 26 (44%) showed a decrease
in size. Tumor size increased in 8 mm in the patients with neuroﬁbromatosis. 8 patients did not have MRI even after 6 months
of treatment to assess it. 5 patients showed progression in hearing loss while another 8 showed an improvement. One patient
showed progression in dizziness and 13 a clear improvement. 4 patients had a temporary and slight facial hypoesthesia and 2
patients have incomplete facial paralysis two months after treatment, both in intracanalicular tumors.
Conclusions. SRS and RTEF with AL and DART with Micromultiláminas achieves low toxicity with an excellent local control and
quality of life.
http://dx.doi.org/10.1016/j.rpor.2013.03.827
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Purpose. In this paper,weused the intra frationmotion review technique (IMR, Varianmedical system),which allows simultaneous
kV/MV utilization to analyse motion management during gated RapidArc treatment.
Materials and Methods. Eight liver cancer patientswith implantedﬁducialmarkerswere treatedusing the gatedRapidArc technique
with a Varian Novalis Truebeam linear accelerator. The ﬁducial markers were implanted inside or close to the tumor target before
treatment simulation. For patient simulation, three to four 4D computed tomography (CT) scans were acquired using Real time
Position Management (RPM) system to study the reproducibility of liver motion. The cine 4D CT images were separated into
10 phases CT series based on respiratory motion information. A Maximum Intensity Projection (MIP) and an Average Intensity
Projection (Ave-IP) CT series were generated. During the treatment planning, the internal target volume (ITV) was outlined in
the MIP CT series. The PTV was created by adding a 5 mm margin from the ITV. In the same stage, the ﬁducial were marked in
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the exhalation phase. The treatment planning is realized in the Ave-IP CT series. Before the treatment delivery, the RPM block
was put on patient’s abdominal surface and the gating signal was generated by the RPM system. Then, the patient’s alignment
is set based on markers using daily cone beam CT (CBCT) and kV/kV matching. During the treatment, kV images were acquired
at each exhalation phase of the breathing cycle and the positions of the ﬁducial markers were compared with their expected
positions. We reported here for the ﬁve ﬁrst fractions the differences between expected and real ﬁducial position, treatment
planning parameters such as the prescription, conformity index CIPTV= (VPTV95% (cc)/VPTV (cc)) * (VPTV95% (cc)/Viso95% (cc)),
homogeneity index HIPTV= (D2%−D98%)/Dmedian and the number of Monitor Unit (UM) per Gray. The treatment delivery
parameters such as kv images acquired per fraction, the fraction’s time and the room occupation’s time were also mentioned.
Results. For the eight PTV patients, the average (±SD) conformity index was 0.93±0.02 and homogeneity index was 0.09±0.02.
Average MU/Gy was 147±25. Maximum deviation in the Superior-Inferior (SI) direction during the intrafraction ranged from 4
mm to 6 mm.
Conclusion. The average gating errors measured were small compare with the 5 mm margin added to the ITV to create the PTV.
However, regarding to maximal error, this additional margin is suitable to treat the tumor with no misses due to the liver motion.
http://dx.doi.org/10.1016/j.rpor.2013.03.828
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Introduction. Stereotactic radiosurgery treatment of arteriovenous malformations (AVM) is a minimally invasive technique. Inci-
dence of complication in the patients is low. Although most complications require medical handling, the most severe can
underwent neurosurgical treatment. We performed a descriptive study of the complications that end up in surgery in our series.
Objective. The aim of this review is to analyze the percentage of surgical complications in stereotactic radiosurgery treatment of
cerebral AVMs.
Method. A total of 175 AVMs were analyzed with a minimum follow-up period of one year. A six-months monitoring clinical-
radiologic protocol was employed by our unit, for three years, complete with angiography at the end of this period, to conﬁrm
the closure of the same.
Results. 84 (48%) patients developed complications, requiring neurosurgical treatment in 12 cases (6%): 5 (2.8%) patients required
external ventricular drainage, 2 (1.1%) required ventriculo-peritoneal valves, 2 (1.1%) underwent craniotomy andhematoma evac-
uation, 2 (1.1%) required craniotomy and excision of radionecrosis area and one case (0.5%) required a decompressive craniotomy
for secondary edema due to early closure of venous drainage.
Conclusions. Although radiosurgery is a safe and effective treatment method is not out of risk, and sometimes neurosurgical
management is required. The most frequent neurosurgical treatment needed in our series is the external ventricular drainage
implantantation due to intraventicular hemorrhage secondary to AVM rupture.
http://dx.doi.org/10.1016/j.rpor.2013.03.829
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Resumen
Introduction.We describe our series of patients treatedwith SBRT since February 2009. Target Analyze dosimetric aspects, obtained
response and tolerance.
Materials and Methods. CT-simulation c/c IV (slice thickness), body stereotactic body frame (ELEKTA (r)) mattress individualized
and diaphragmatic compression. Post-immobilization ﬂuoroscopy to determine three-dimensional displacement (PTV margins).
Image Fusion (PET-CT/RMI). SYNERGY (r) multi-energy linear accelerator. Isocenter stereotactic localization (Dynatrac (r)). Robotic
table (6 degrees of freedom-Hexapod (r)). Image-Guided Radiotherapy (IGRT) cone beam. We included 67 treatments (39 patients)
treated from February 2009 to date. Only 8 primary (hepatocellular carcinoma, pancreatic, lung). 19 women, average age: 60 years
(28-95). SBRT lung (30), liver (11), spine (10), adrenal (9), other sites (7): cavum, chordoma sacrum, sternum, nostril, pancreas,
